Stability of two extemporaneously prepared oral metoprolol and carvedilol liquids

Hospital Pharmacy

Volumn 41, Issue 3, 2006, Pages 254-259

  Yamreudeewong, Weeranuj ^a,b   Dolence, E Kurt ^a   Pahl, Deborah ^b  

^a UNIVERSITY OF WYOMING SCHOOL OF PHARMACY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Carvedilol; Extemporaneously prepared oral liquids; Metoprolol; Stability

Indexed keywords

CARVEDILOL; METOPROLOL;

AQUEOUS SOLUTION; ARTICLE; DECOMPOSITION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW TEMPERATURE; MICROBIAL GROWTH; NONHUMAN; PLASTIC BOTTLE; POWDER; REFRIGERATOR; ROOM TEMPERATURE;

EID: 33645552193     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4103-254     Document Type: Article

References (8)

1. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on mortality and morbidity in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.
2. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effect of controlled-release metoprolol on total mortality, hospitalizations, and well being with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart failure (MERIT-HP). MERIT-HF Study Group. JAMA. 2000;283:1295-1302.
3. Hunt SA, Baker DW, Chin MH, et al. 2001 ACC/AHA Guidelines for evaluation and management of chronic heart failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the evaluation and management of heart failure). Available at: http://www.acc.org/clinical/ guidelines/failure/hf_index.htm. Accessed on March 21, 2005.
4. Allen LV, Erickson MA III. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids. Am J Health Syst Pharm. 1996;53:2304-2309.
5. Peterson GM, Meaney MF, Reid CA, et al. Stability of extemporaneously prepared mixtures of metoprolol and spironolactone. Aust J Hosp Pharm. 1989;19:344-346.
6. th ed. Rockville, MD: The United States Pharmacopeial Convention; 1994:1015-1016.
7. Behn F, Laer S, Scholz H. Determination of carvedilol in human cardiac tissue by high performance liquid chromatography. J. Chromatogr Sci. 2001;39:121-124.
8. Eisenberg EJ, Patterson WR, Kahn GC. High-performance liquid chromatographic method for the simultaneous determination of the enantiomers of carvedilol and its O-desmethyl metabolite in human plasma after chiral derivatization. J. Chromatogr. 1989;493:105-115.